Provided by Tiger Trade Technology Pte. Ltd.

Collegium Pharmaceutical

22.29
+0.10000.45%
Volume:276.21K
Turnover:6.18M
Market Cap:725.66M
PE:17.55
High:22.64
Open:22.36
Low:22.14
Close:22.19
52wk High:50.79
52wk Low:21.65
Shares:32.56M
Float Shares:31.37M
Volume Ratio:0.53
T/O Rate:0.88%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.27
EPS(LYR):1.73
ROE:17.61%
ROA:5.75%
PB:2.33
PE(LYR):12.88

Loading ...

Collegium Pharmaceutical Outlook FY Adjusted Ebitda USD 445-470 Million

THOMSON REUTERS
·
Aug 06

Collegium Pharmaceutical Outlook FY Revenue USD 825-855 Million

THOMSON REUTERS
·
Aug 06

How Collegium's Quarterly Beat but Softer Outlook Could Reframe Collegium Pharmaceutical (COLL) Investors

Simply Wall St.
·
Jul 29

Collegium Pharmaceutical to Report Q2 2026 Results, Host Earnings Call

Reuters
·
Jul 23

Collegium Pharmaceutical Announces New Corporate Headquarters at One Lincoln in Boston

GlobeNewswire
·
Jul 20

Engene Names Michael Heffernan Board Chairman as Richard Glickman Steps Down

Reuters
·
Jul 16

Is Collegium Pharmaceutical (COLL) A Bargain On Its Azstarys Deal And 2026 Guidance?

Simply Wall St.
·
Jul 04

Collegium Amends 8-K to Add Corium Therapeutics Audited Financial Statements

Reuters
·
Jul 01

Did Collegium Pharmaceutical’s Profitability Surge and Efficiency Gains Just Shift COLL’s Investment Narrative?

Simply Wall St.
·
Jun 21

Collegium Pharmaceutical awards 50,305 RSUs to 34 newly hired employees under inducement plan

Reuters
·
Jun 05

Collegium Pharmaceutical Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Jun 05

Collegium Pharma director John Gordon Freund sells 20 shares for $681

Reuters
·
May 21

Collegium director John Gordon Freund disposes 4,127 shares for $142,557.58

Reuters
·
May 19

Collegium Pharma director Michael Donovan files initial beneficial ownership statement

Reuters
·
May 19

Collegium Pharmaceutical shareholders elect eight directors at annual meeting

Reuters
·
May 16

Collegium Pharma director Nancy Lurker disposes 4,500 shares for $161,861.06

Reuters
·
May 16

Collegium Pharmaceutical Rocked by Eye-Catching Insider Stock Move

TIPRANKS
·
May 14

Collegium Pharma director Garen G. Bohlin disposes 8,700 shares for $323,493.23

Reuters
·
May 14

Barclays Keeps Their Buy Rating on Collegium Pharmaceutical (COLL)

TIPRANKS
·
May 13

BRIEF-Collegium Completes Acquisition Of Azstarys® From Corium Therapeutics

Reuters
·
May 12